A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy

Background. According to the World Health Organization, about 50 million people worldwide suffer from epilepsy. Almost 1/3 of patients are diagnosed with drug-resistant epilepsy (DRE). A relationship between intestinal microbiome (IM) and the central nervous system carried out throughout life via bi...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Cherednichenko, P. V. Mozdor, T. K. Oleynikova, P. A. Khatam, F. M. Nastueva, K. O. Kovalenkov, A. S. Serdinova, A. Kh. Osmaeva, A. I. Rovchak, Yu. Yu. Esikova, M. Kh. Shogenova, K. I. Akhmedov, M. R. Amirgamzaev, E. R. Batyrshina
Format: Article
Language:Russian
Published: IRBIS LLC 2024-10-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/1050
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839584040626159616
author A. S. Cherednichenko
P. V. Mozdor
T. K. Oleynikova
P. A. Khatam
F. M. Nastueva
K. O. Kovalenkov
A. S. Serdinova
A. Kh. Osmaeva
A. I. Rovchak
Yu. Yu. Esikova
M. Kh. Shogenova
K. I. Akhmedov
M. R. Amirgamzaev
E. R. Batyrshina
author_facet A. S. Cherednichenko
P. V. Mozdor
T. K. Oleynikova
P. A. Khatam
F. M. Nastueva
K. O. Kovalenkov
A. S. Serdinova
A. Kh. Osmaeva
A. I. Rovchak
Yu. Yu. Esikova
M. Kh. Shogenova
K. I. Akhmedov
M. R. Amirgamzaev
E. R. Batyrshina
author_sort A. S. Cherednichenko
collection DOAJ
description Background. According to the World Health Organization, about 50 million people worldwide suffer from epilepsy. Almost 1/3 of patients are diagnosed with drug-resistant epilepsy (DRE). A relationship between intestinal microbiome (IM) and the central nervous system carried out throughout life via bidirectional dynamic network exists. It has been evidenced that IM profile becomes altered in patients with DRE.Objective: to summarize the current literature data on the role for microbiome-gut-brain axis in DRE, as well as to assess an importance of IM composition changes as a prognostic marker for developing DRE.Material and methods. The authors conducted a search for publications in the electronic databases PubMed/MEDLINE and eLibrary, as well as Google Scholar search engine. The evaluation of the articles was carried out in accordance with the PRISMA recommendations. Based on the search, 4,158 publications were retrieved from PubMed/MEDLINE database, 173 – from eLibrary, and 1,100 publications found with  Google Scholar. After the selection procedure, 121 studies were included in the review.Results. The review provides convincing evidence about a correlation between IM and DRE demonstrating overt differences in IM composition found in patients with epilepsy related to drug sensitivity. IM dysbiosis can be corrected by exogenous interventions such as ketogenic diet, probiotic treatment and fecal microbiota transplantation subsequently resulting in altered brain neurochemical signaling and, therefore, alleviating epileptic activity.Conclusion. A ketogenic diet, probiotics and antibiotics may have some potential to affect epilepsy by correcting IM dysbiosis, but the current studies provide no proper level of evidence. Future clinical multicenter trials should use standardized protocols and a larger-scale patient sample to provide more reliable evidence. Moreover, further fundamental investigations are required to elucidate potential mechanisms and therapeutic targets.
format Article
id doaj-art-4282642c712b4d2192746b83c63e13e3
institution Matheson Library
issn 2077-8333
2311-4088
language Russian
publishDate 2024-10-01
publisher IRBIS LLC
record_format Article
series Эпилепсия и пароксизмальные состояния
spelling doaj-art-4282642c712b4d2192746b83c63e13e32025-08-03T19:51:23ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882024-10-0116325026510.17749/2077-8333/epi.par.con.2024.190646A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsyA. S. Cherednichenko0P. V. Mozdor1T. K. Oleynikova2P. A. Khatam3F. M. Nastueva4K. O. Kovalenkov5A. S. Serdinova6A. Kh. Osmaeva7A. I. Rovchak8Yu. Yu. Esikova9M. Kh. Shogenova10K. I. Akhmedov11M. R. Amirgamzaev12E. R. Batyrshina13Central City HospitalKrasnoarmeyskaya Central District HospitalKursk State Medical UniversityMaikop State Technological UniversityStavropol State Medical UniversityStavropol State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRussian University of MedicineRussian University of MedicineNorth Ossetian State Medical AcademyCity Clinical Hospital No. 18Background. According to the World Health Organization, about 50 million people worldwide suffer from epilepsy. Almost 1/3 of patients are diagnosed with drug-resistant epilepsy (DRE). A relationship between intestinal microbiome (IM) and the central nervous system carried out throughout life via bidirectional dynamic network exists. It has been evidenced that IM profile becomes altered in patients with DRE.Objective: to summarize the current literature data on the role for microbiome-gut-brain axis in DRE, as well as to assess an importance of IM composition changes as a prognostic marker for developing DRE.Material and methods. The authors conducted a search for publications in the electronic databases PubMed/MEDLINE and eLibrary, as well as Google Scholar search engine. The evaluation of the articles was carried out in accordance with the PRISMA recommendations. Based on the search, 4,158 publications were retrieved from PubMed/MEDLINE database, 173 – from eLibrary, and 1,100 publications found with  Google Scholar. After the selection procedure, 121 studies were included in the review.Results. The review provides convincing evidence about a correlation between IM and DRE demonstrating overt differences in IM composition found in patients with epilepsy related to drug sensitivity. IM dysbiosis can be corrected by exogenous interventions such as ketogenic diet, probiotic treatment and fecal microbiota transplantation subsequently resulting in altered brain neurochemical signaling and, therefore, alleviating epileptic activity.Conclusion. A ketogenic diet, probiotics and antibiotics may have some potential to affect epilepsy by correcting IM dysbiosis, but the current studies provide no proper level of evidence. Future clinical multicenter trials should use standardized protocols and a larger-scale patient sample to provide more reliable evidence. Moreover, further fundamental investigations are required to elucidate potential mechanisms and therapeutic targets.https://www.epilepsia.su/jour/article/view/1050drug-resistant epilepsydreintestinal microbiotaintestinal microbiomeimmicrobiome-gut-brain axismgba
spellingShingle A. S. Cherednichenko
P. V. Mozdor
T. K. Oleynikova
P. A. Khatam
F. M. Nastueva
K. O. Kovalenkov
A. S. Serdinova
A. Kh. Osmaeva
A. I. Rovchak
Yu. Yu. Esikova
M. Kh. Shogenova
K. I. Akhmedov
M. R. Amirgamzaev
E. R. Batyrshina
A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
Эпилепсия и пароксизмальные состояния
drug-resistant epilepsy
dre
intestinal microbiota
intestinal microbiome
im
microbiome-gut-brain axis
mgba
title A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
title_full A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
title_fullStr A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
title_full_unstemmed A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
title_short A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
title_sort relationship between intestinal microbiome and epilepsy potential treatment options for drug resistant epilepsy
topic drug-resistant epilepsy
dre
intestinal microbiota
intestinal microbiome
im
microbiome-gut-brain axis
mgba
url https://www.epilepsia.su/jour/article/view/1050
work_keys_str_mv AT ascherednichenko arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT pvmozdor arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT tkoleynikova arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT pakhatam arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT fmnastueva arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT kokovalenkov arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT asserdinova arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT akhosmaeva arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT airovchak arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT yuyuesikova arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT mkhshogenova arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT kiakhmedov arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT mramirgamzaev arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT erbatyrshina arelationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT ascherednichenko relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT pvmozdor relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT tkoleynikova relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT pakhatam relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT fmnastueva relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT kokovalenkov relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT asserdinova relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT akhosmaeva relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT airovchak relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT yuyuesikova relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT mkhshogenova relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT kiakhmedov relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT mramirgamzaev relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy
AT erbatyrshina relationshipbetweenintestinalmicrobiomeandepilepsypotentialtreatmentoptionsfordrugresistantepilepsy